The German scientist speaks with 'La Vanguardia' about the potential of mRNA against cancer, her decision to leave BioNTech, and the value of diversity in laboratories.

Uğur Şahin és Özlem Türeci új mRNS-startupot alapítanak.

BioNTech founders Uğur Şahin and Özlem Türeci are embarking on a new venture, with their original investors and co-founders, Thomas and Andreas Strüngmann, expressing interest in investing again. This move follows their stepping back from BioNTech's leadership, highlighting their continued focus on scientific innovation and entrepreneurship.

Dass sich Ugur Sahin und Özlem Türeci aus dem operativen Geschäft von Biontech zurückziehen, erscheint zunächst seltsam.

With their Covid vaccines, Ugur Sahin and Özlem Türeci became world-famous overnight. Now the doctor couple prefers to research again instead of managing.

Ugur Sahin and Özlem Türeci, the founders of BioNTech, are reportedly stepping back from the company's operational management, a move described as a potentially strategic decision by the research couple.